Last reviewed · How we verify
alendronate with cholecalciferol
alendronate with cholecalciferol is a Small molecule drug developed by Hebrew SeniorLife. It is currently in Phase 3 development. Also known as: Fosamax Plus D®.
At a glance
| Generic name | alendronate with cholecalciferol |
|---|---|
| Also known as | Fosamax Plus D® |
| Sponsor | Hebrew SeniorLife |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
- Back pain
- Nasopharyngitis
- Arthralgia
- Upper respiratory tract infection
- Urinary tract infection
- Dyspepsia
- Abdominal pain upper
- Urine calcium increased
- Myalgia
- Bronchitis
- Diarrhoea
- Headache
Key clinical trials
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis (NA)
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease (PHASE4)
- Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
- Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover (PHASE4)
- Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
- A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) (PHASE3)
- A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) (PHASE3)
- A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- alendronate with cholecalciferol CI brief — competitive landscape report
- alendronate with cholecalciferol updates RSS · CI watch RSS
- Hebrew SeniorLife portfolio CI
Frequently asked questions about alendronate with cholecalciferol
What is alendronate with cholecalciferol?
alendronate with cholecalciferol is a Small molecule drug developed by Hebrew SeniorLife.
Who makes alendronate with cholecalciferol?
alendronate with cholecalciferol is developed by Hebrew SeniorLife (see full Hebrew SeniorLife pipeline at /company/hebrew-seniorlife).
Is alendronate with cholecalciferol also known as anything else?
alendronate with cholecalciferol is also known as Fosamax Plus D®.
What development phase is alendronate with cholecalciferol in?
alendronate with cholecalciferol is in Phase 3.
What are the side effects of alendronate with cholecalciferol?
Common side effects of alendronate with cholecalciferol include Back pain, Nasopharyngitis, Arthralgia, Upper respiratory tract infection, Urinary tract infection, Dyspepsia.
Related
- Manufacturer: Hebrew SeniorLife — full pipeline
- Also known as: Fosamax Plus D®
- Compare: alendronate with cholecalciferol vs similar drugs
- Pricing: alendronate with cholecalciferol cost, discount & access